DekaBank Deutsche Girozentrale’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-3,500
| Closed | -$240K | – | 1272 |
|
|
2019
Q3 | $240K | Sell |
3,500
-3,500
| -50% | -$240K | ﹤0.01% | 835 |
|
|
2019
Q2 | $394K | Buy |
7,000
+200
| +3% | +$11.3K | ﹤0.01% | 948 |
|
|
2019
Q1 | $413K | Buy |
6,800
+3,300
| +94% | +$200K | ﹤0.01% | 941 |
|
|
2018
Q4 | $223K | Sell |
3,500
-3,300
| -49% | -$210K | ﹤0.01% | 952 |
|
|
2018
Q3 | $413K | Sell |
6,800
-200
| -3% | -$12.1K | ﹤0.01% | 963 |
|
|
2018
Q2 | $350K | Sell |
7,000
-10,000
| -59% | -$500K | ﹤0.01% | 978 |
|
|
2018
Q1 | $529K | Sell |
17,000
-300
| -2% | -$9.34K | ﹤0.01% | 861 |
|
|
2017
Q4 | $525K | Hold |
17,300
| – | – | ﹤0.01% | 809 |
|
|
2017
Q3 | $525K | Hold |
17,300
| – | – | ﹤0.01% | 815 |
|
|
2017
Q2 | $567K | Hold |
17,300
| – | – | ﹤0.01% | 811 |
|
|
2017
Q1 | $551K | Sell |
17,300
-1,500
| -8% | -$47.8K | 0.01% | 725 |
|
|
2016
Q4 | $558K | Buy |
18,800
+1,400
| +8% | +$41.6K | 0.01% | 641 |
|
|
2016
Q3 | $489K | Hold |
17,400
| – | – | 0.01% | 672 |
|
|
2016
Q2 | $457K | Buy |
17,400
+3,400
| +24% | +$89.3K | 0.01% | 693 |
|
|
2016
Q1 | $343K | Sell |
14,000
-2,500
| -15% | -$61.3K | ﹤0.01% | 727 |
|
|
2015
Q4 | $582K | Buy |
16,500
+300
| +2% | +$10.6K | 0.01% | 667 |
|
|
2015
Q3 | $343K | Buy |
16,200
+800
| +5% | +$16.9K | ﹤0.01% | 764 |
|
|
2015
Q2 | $428K | Buy |
15,400
+500
| +3% | +$13.9K | 0.01% | 732 |
|
|
2015
Q1 | $455K | Sell |
14,900
-2,000
| -12% | -$61.1K | 0.01% | 742 |
|
|
2014
Q4 | $548K | Sell |
16,900
-1,600
| -9% | -$51.9K | 0.01% | 672 |
|
|
2014
Q3 | $524K | Buy |
18,500
+600
| +3% | +$17K | 0.01% | 645 |
|
|
2014
Q2 | $490K | Sell |
17,900
-900
| -5% | -$24.6K | 0.01% | 601 |
|
|
2014
Q1 | $495K | Buy |
18,800
+1,400
| +8% | +$36.9K | 0.01% | 576 |
|
|
2013
Q4 | $509K | Buy |
17,400
+500
| +3% | +$14.6K | 0.01% | 544 |
|
|
2013
Q3 | $517K | Buy |
+16,900
| New | +$517K | 0.01% | 544 |
|